EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Plasmodium falciparum African PfCRT Mutant Isoforms Conducive to Piperaquine Resistance Are Infrequent and Impart a Major Fitness Cost

Laura M Hagenah, Tomas Yeo, Kyra A Schindler iD, Jin H Jeon, Talia S Bloxham iD, Jennifer L Small-Saunders, Sachel Mok, David A Fidock iD

The Journal of Infectious Diseases · 02.06.2025 · 231 (5) · e976-e985

DOI: 10.1093/infdis/jiae617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 11.12.2024. Verfasst von Laura M Hagenah und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology. Hauptthemen laut MEDLINE: Quinolines, Plasmodium falciparum, Drug Resistance, Antimalarials. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, Doris Duke Physician Scientist, Columbia University Graduate Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Piperaquine, used in combination with dihydroartemisinin, has been identified as a promising partner drug for uncomplicated treatment and chemoprevention of Plasmodium falciparum malaria in Africa. In light of the earlier spread of piperaquine resistance in Southeast Asia, mediated primarily by mutations in the drug efflux transporter PfCRT, we have explored whether PfCRT mutations would represent a probable path to piperaquine resistance becoming established in Africa.

Methods

We edited PfCRT mutations known to mediate piperaquine resistance in Southeast Asia into P falciparum asexual blood-stage parasites expressing 3 prevalent African mutant PfCRT haplotypes. Gene-edited clones were profiled in antimalarial concentration-response and competitive fitness assays. Results pfcrt-edited parasites expressing the contemporary Southeast Asian T93S or I218F mutations added to the GB4 and Cam783 haplotypes common in Africa did not mediate piperaquine resistance, with partial survival only at low drug concentrations. In contrast, parasites expressing these mutations on the rare PfCRT FCB haplotype, observed mostly in Northeast Africa, acquired a moderate level of piperaquine resistance. Dd2GB4, Dd2Cam783, and Dd2FCB lines edited to express the T93S or I218F mutations showed increased susceptibility to chloroquine. Piperaquine-resistant African PfCRT isoforms conferred a substantial fitness cost, manifesting as reduced asexual blood-stage parasite growth rates.

Conclusions

These findings suggest that piperaquine-resistant PfCRT mutations that emerged in Southeast Asia mediate resistance only in a limited subset of African PfCRT haplotypes, with fitness costs that we suspect would likely preclude dissemination in high-transmission malaria-endemic African regions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuinolinesPlasmodium falciparumDrug ResistanceAntimalarialsProtozoan ProteinsMembrane Transport ProteinsMutationHumansMalaria, FalciparumHaplotypesAfricaProtein IsoformsAsia, SoutheasternPiperazines

Stichwörter der Autor:innen

Plasmodium falciparumPfCRTfitnessmalaria chemopreventionpiperaquine resistance

Substanzen

piperaquineQuinolinesPfCRT protein, Plasmodium falciparumAntimalarialsProtozoan ProteinsMembrane Transport ProteinsProtein IsoformsPiperazines

Autor:innen und Institutionen

  • Department of Microbiology and Immunology.
  • Center for Malaria Therapeutics and Antimicrobial Resistance.
  • Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York.

ORCID-Profile: Kyra A Schindler, Talia S Bloxham, David A Fidock

Förderung

  • NIAID NIH HHS
  • Doris Duke Physician Scientist
  • Columbia University Graduate Program
  • Microbiology and Immunology
  • NIH HHS
  • Doris Duke Charitable Foundation
  • L. M. H.
  • National Institutes of Health (NIH)

Zitieren

APA

Hagenah, L. M., Yeo, T., Schindler, K. A., Jeon, J. H., Bloxham, T. S., Small-Saunders, J. L., Mok, S., & Fidock, D. A. (2025). Plasmodium falciparum African PfCRT Mutant Isoforms Conducive to Piperaquine Resistance Are Infrequent and Impart a Major Fitness Cost. The Journal of Infectious Diseases, 231(5), e976-e985. https://doi.org/10.1093/infdis/jiae617

Vancouver

Hagenah LM, Yeo T, Schindler KA, Jeon JH, Bloxham TS, Small-Saunders JL, et al. Plasmodium falciparum African PfCRT Mutant Isoforms Conducive to Piperaquine Resistance Are Infrequent and Impart a Major Fitness Cost. The Journal of Infectious Diseases. 2025;231(5):e976-e985. doi:10.1093/infdis/jiae617

BibTeX
@article{Hagenah2025,
  author = {Hagenah, Laura M and Yeo, Tomas and Schindler, Kyra A and Jeon, Jin H and Bloxham, Talia S and Small-Saunders, Jennifer L and Mok, Sachel and Fidock, David A},
  title = {Plasmodium falciparum African PfCRT Mutant Isoforms Conducive to Piperaquine Resistance Are Infrequent and Impart a Major Fitness Cost},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  volume = {231},
  number = {5},
  pages = {e976--e985},
  doi = {10.1093/infdis/jiae617}
}
Kostenlos starten →